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Chagas disease, caused by the parasite Trypanosoma cruzi, was
once thought to be an exotic disease, confined to endemic areas of
Latin America and hence of little importance to anyone outside of
these endemic regions, including most physicians and scientists.
The impact of the lack of physician awareness and lack of scientific
attention is undefined, but may contribute to the continued neglect
of Chagas disease and the affected populations. Despite historical
evidence and growing recognition of the spread of Chagas disease,
the prevention and control of this disease outside of Latin America
is only now being addressed.
Chagasdiseasewasrecognized inthe United Statesasearly asthe
1950s, when the first reports of local vector-borne cases were
published [1]. More recently, immigration patterns from endemic
countries have changed the epidemiology of this disease in the US.
In 1985, Kirchhoff reported three Bolivian immigrants who
presented to the US National Institutes of Health with clinical
Chagas disease [2], and in 1987 a survey of Central American
immigrants in the Washington, D.C., area revealed a 4.9%
prevalence of Chagas disease in this population [3]. Shortly after
these reports, cases of transfusion-associated Chagas disease were
identified in New York City, US, and Manitoba, Canada [4,5]. In
the New York City case, the donor was traced to a Bolivian
immigrant and the recipient was a 12-year-old girl with Hodgkin’s
disease. Kirchhoff, in an accompanying editorial, raised the alarm
asto whetherthebloodsupplywassafe [6]; however,itwasnot until
15 years later that a screening test for Chagas disease was approved
by FDAand implemented by the American blood banking industry.
To date, this screening has resulted in the recognition of over 1,300
cases of Chagas disease in donors (http://www.aabb.org/pro
grams/biovigilance/Pages/chagas.aspx), the vast majority of which
have been asymptomatic representing the indeterminate form of
chronic infection.
In other parts of the world, immigration alone has contributed
to the appearance of Chagas disease in non-endemic countries [7–
10]. Immigration from endemic regions is widespread; for
example, there are Brazilian immigrants in Portugal and Bolivian
immigrants in Spain, and currently, there are an estimated
100,000 or more Latin American immigrants living in France.
With immigration has come Chagas disease. Chagasic heart
disease has been reported in Brazilian immigrants of Japanese
origin in Japan [8], and the seroprevalence of Chagas disease
among Bolivian women in Barcelona has been determined to be
3.4% [8].
In all parts of the world where people at risk for Chagas disease
are found, Chagas disease in immune-suppressed patients has
become an important consideration, resulting in organ and tissue
safety concerns related to both donors and recipients. In non-
endemic areas, screening of donors or recipients may not be
performed routinely. Furthermore, individuals with chronic
Chagas disease who acquire HIV/AIDS may have a recrudes-
cence of the infection that can go unrecognized or misdiagnosed as
Toxoplasma encephalitis.
Most of those infected have the indeterminate, asymptomatic
form of Chagas disease and are unaware of their infection, but
remain potential sources of transmission. Pregnant women
unaware of their infection can be sources of congenital
transmission. Congenital Chagas disease has now been reported
in Europe among infants born to mothers who are Latin American
immigrants with undiagnosed Chagas disease [11–13]. These
observations raise the issue as to whether prescreening of pregnant
women for Chagas disease should be recommended for immi-
grants from Chagas-endemic areas. This issue was recently
highlighted in a paper by Verani et al. [14], who conducted a
survey of obstetricians and gynecologists in the US, and
demonstrated that clinicians had an inadequate understanding of
basic information about this disease and no knowledge of the fact
that Chagas disease could be transmitted from mother to child.
The paper in this issue of PLoS Neglected Tropical Diseases by Roca
et al. [15] examined the prevalence of Chagas disease among
Latin American immigrants in a primary care setting in Barcelona,
which has become a destination of Spanish-speaking immigrants
from Chagas-endemic areas. Of the 766 patients tested, 22
individuals were diagnosed with T. cruzi infection (a prevalence of
2.8%); more women were positive than men (54.6% versus
45.5%). Interestingly, 21 patients were from Bolivia, which is a
highly endemic area. The prevalence rate among Bolivian
immigrants in this study was 16.5%. Many had lived in
substandard adobe houses that have been associated with risk
for transmission while in Bolivia, and had previous knowledge of
Chagas disease in their country of origin. A number of these
patients had clinical Chagas disease, including cardiac and
gastrointestinal manifestations.
Awareness that Chagas disease is now found in places far from
endemic areas of Latin America is important because it leads to
the development of strategies to prevent potential sources of
transmission (e.g., blood transfusion, organ transplantation, or
congenital transmission), and to identify individuals who may
benefit from anti-parasitic therapy. Increased awareness also
enables us to identify patients who may have a diagnosis of
ischemic heart disease or cardiomyopathy of unknown etiology or
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whose illness is actually Chagas disease, improving the ability of
physicians to care for these patients appropriately. Indeed, it is
evident that the challenges of Chagas disease have become global.
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